Literature DB >> 11265957

Enterococcal vanB resistance locus in anaerobic bacteria in human faeces.

T P Stinear, D C Olden, P D Johnson, J K Davies, M L Grayson.   

Abstract

While developing a rapid method to detect carriers of vancomycin-resistant enterococci (VRE), we found the vanB gene by PCR in 13 of 50 human faecal specimens that did not contain culturable VRE. Passaging under antibiotic selection allowed us to isolate two species of anaerobic bacteria that were vanB PCR positive, vancomycin resistant, and teicoplanin sensitive. Sequence analysis of the 16S rRNA genes showed that one isolate resembled Eggerthella lenta (98% identity), and the other Clostridium innocuum (92% identity). Southern hybridisation and nucleotide sequencing showed a vanB locus homologous to that in VRE. We propose that vanB resistance in enterococci might arise from gene transfer in the human bowel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11265957     DOI: 10.1016/S0140-6736(00)04206-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococci.

Authors:  Suzanne M Paule; William E Trick; Fred C Tenover; Mary Lankford; Susan Cunningham; Valentina Stosor; Ralph L Cordell; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 2.  Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need.

Authors:  Daniel J Diekema; Kirsty J Dodgson; Bryndis Sigurdardottir; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli.

Authors:  S A Ballard; E A Grabsch; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 4.  Engineering the microbiome for animal health and conservation.

Authors:  Se Jin Song; Douglas C Woodhams; Cameron Martino; Celeste Allaband; Andre Mu; Sandrine Javorschi-Miller-Montgomery; Jan S Suchodolski; Rob Knight
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-18

5.  Eggerthella lenta bacteremia complicated by spondylodiscitis, psoas abscess, and meningitis.

Authors:  B J Gardiner; T M Korman; R K Junckerstorff
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

6.  High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora.

Authors:  M-C Domingo; A Huletsky; R Giroux; K Boissinot; F J Picard; P Lebel; M J Ferraro; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  Analysis of the mobilization functions of the vancomycin resistance transposon Tn1549, a member of a new family of conjugative elements.

Authors:  Krassimira Tsvetkova; Jean-Christophe Marvaud; Thierry Lambert
Journal:  J Bacteriol       Date:  2009-12-04       Impact factor: 3.490

8.  Transferable vanB2 Tn5382-containing elements in fecal streptococcal strains from veal calves.

Authors:  Kristin H Dahl; Arnfinn Sundsfjord
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.

Authors:  Alexander A Padiglione; Rory Wolfe; Elizabeth A Grabsch; Di Olden; Stephen Pearson; Clare Franklin; Denis Spelman; Barrie Mayall; Paul D R Johnson; M Lindsay Grayson
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

10.  Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice.

Authors:  Aline Launay; Susan A Ballard; Paul D R Johnson; M Lindsay Grayson; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.